Studies on bone volume regulation are essential to our long term goals, which are to cure and prevent osteoporosis. Bone volume is determined by the rates of bone formation and bone resorption and recent research in several laboratories including ours suggest that growth factors may act locally to modulate bone formation by stimulating both osteoblast proliferation and activity. To this end we have purified to apparent homogeneity, a bone cell growth factor termed Skeletal Growth Factor (SGF) from human bone matrix and our studies on the structure of human SGF revealed sequence homology with human IGF-II. We found multiple growth factors including SGF/IGF-II, IGF-I, TGF-B, PDGF and basic FGF in humans bone matrix and in human bone cell conditioned medium. Based on past studies we and others have proposed the concept that local production of growth factors plays a key role in the regulation of bone metabolism. The primary focus of this project will e to investigate the regulation of synthesis and secretion of SGF/IGF- II and its binding proteins. In this regard, we will test 3 relevant hypotheses: 1) That SGF/IGF-II synthesis is regulated at several different steps, i.e., a modest of 8 control points (ranging from transcription to binding in ECF byu binding protein) is presented, each one of which will be studied. Additionally, we will purify SGF.IGF-II binding proteins from bone cell conditioned medium and from human bone matrix and determine the effects of binding proteins on SGF/IGF-II induced cell proliferation and matrix x synthesis. 2) That regulatory agents for growth factor synthesis are different for different growth factors. Those to be compare with SGF.IGF-II include IGF-I, TGFB and basic FGF. We will also determine if synthesis of SGF/IGF-II and collagen are coregulated or independently regulated, 3) That SGF and other growth factored upon secretion by bonecells are partitioned into two compartments, a)bone matrix (growth factors in this compartment could act at a later time following release by osteoclast) and b) ECF (growth factors in this compartment could avt acutely to regulate the proliferation and mature cell functions of osteoblasts), We will evaluted this hypotesis by testing various effectors on this partitioning. The propose studies will be carries out using in vitro experimental model systems (bone cells and vone organs in culture), SGF/IGF-II specific antibodies, an SGF/IGF-II cDNA prove, radiolavelled SGF and validated growth factors assays. It is anticipated that theses studies will provide valuable information of bone formation at the local level.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR031062-07
Application #
3155957
Study Section
General Medicine B Study Section (GMB)
Project Start
1981-08-01
Project End
1993-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
7
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Loma Linda University
Department
Type
Schools of Medicine
DUNS #
City
Loma Linda
State
CA
Country
United States
Zip Code
92350
Wergedal, Jon E; Kesavan, Chandrasekhar; Brommage, Robert et al. (2015) Role of WNT16 in the regulation of periosteal bone formation in female mice. Endocrinology 156:1023-32
Simon, Nathan C; Barbieri, Joseph T (2014) Bacillus cereus Certhrax ADP-ribosylates vinculin to disrupt focal adhesion complexes and cell adhesion. J Biol Chem 289:10650-9
Alshbool, Fatima Z; Mohan, Subburaman (2014) Differential expression of claudin family members during osteoblast and osteoclast differentiation: Cldn-1 is a novel positive regulator of osteoblastogenesis. PLoS One 9:e114357
Alshbool, Fatima Z; Mohan, Subburaman (2014) Emerging multifunctional roles of Claudin tight junction proteins in bone. Endocrinology 155:2363-76
Kim, Ha-Young; Alarcon, Catrina; Pourteymour, Sheila et al. (2013) Disruption of claudin-18 diminishes ovariectomy-induced bone loss in mice. Am J Physiol Endocrinol Metab 304:E531-7
Xing, Weirong; Liu, Jeff; Cheng, Shaohong et al. (2013) Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis. J Bone Miner Res 28:1962-74
Linares, Gabriel R; Brommage, Robert; Powell, David R et al. (2012) Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiation. J Bone Miner Res 27:1553-65
Kiepe, Daniela; Rüth, Eva-Maria; Blum, Werner F et al. (2010) The IGF/IGFBP system in relation to macroscopic bone architecture in pediatric renal transplant patients. Pediatr Nephrol 25:659-67
Ohlsson, Claes; Mohan, Subburaman; Sjögren, Klara et al. (2009) The role of liver-derived insulin-like growth factor-I. Endocr Rev 30:494-535
Linares, Gabriel R; Xing, Weirong; Govoni, Kristen E et al. (2009) Glutaredoxin 5 regulates osteoblast apoptosis by protecting against oxidative stress. Bone 44:795-804

Showing the most recent 10 out of 147 publications